Evidence map›Paper›PMID 19782705›Full record

ArticleBiochimica et biophysica acta2009

Mixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-induced cell death.

Eric T Cole, Yu Zhan, Widian F Abi Saab, Amanda C Korchnak, Brian P Ashburner, Deborah N Chadee

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.Liver international : official journal of the International Association for the Study of the Liver · 2014
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eric T ColeDepartment of Biological Sciences, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.
Yu Zhan
Widian F Abi Saab
Amanda C Korchnak
Brian P Ashburner
Deborah N Chadee
University of Toledo · US

Funding

Regulation of Mixed Lineage Kinase 3 by the tumor suppressor protein MerlinR15CA132006 · NCI · UNIVERSITY OF TOLEDO · PI CHADEE, DEBORAH N · 2008 to 2008
$216k
NCI NIH HHS 1 R15 CA132006-01NCI NIH HHS R15 CA132006
6 · The paper itself

Abstract

Mixed lineage kinase 3 (MLK3) is a mitogen activated protein kinase kinase kinase (MAP3K) that activates multiple MAPK signaling pathways. Nuclear factor kappa B (NF-kappaB) is a transcription factor that has important functions in inflammation, immunity and cell survival. We found that silencing mlk3 expression with RNA interference (RNAi) in SKOV3 human ovarian cancer epithelial cells and NIH-3T3 murine fibroblasts led to a reduction in the level of the inhibitor of kappa B alpha (IkappaBalpha) protein. In addition, we observed enhanced basal IkappaB kinase (IKK) activity in HEK293 cells transiently transfected with MLK3 siRNA and in NIH3T3 cells stably expressing MLK3 shRNA (shMLK3). Furthermore, the basal level of NF-kappaB-dependent gene transcription was elevated in shMLK3 cells. Silencing mlk3 expression conferred resistance of cells to etoposide-induced apoptotic cell death and overexpression of wild type MLK3 (MLK3-WT) or kinase-dead MLK3 (MLK3-KD) promoted apoptotic cell death and cleavage of poly (ADP-ribose) polymerase (PARP). Overexpression of MLK3-WT or MLK3-KD enhanced etoposide-induced apoptotic cell death and cleavage of PARP. These data suggest that MLK3 functions to limit IKK activity, and depleting MLK3 helps protect cells from etoposide-induced cell death through activation of IKK-dependent signaling.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorEtoposideHumansI-kappa B KinaseI-kappa B ProteinsMAP Kinase Kinase KinasesMAP Kinase Signaling SystemMiceMitogen-Activated Protein Kinase Kinase Kinase 11NIH 3T3 CellsPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesAntineoplastic Agents, PhytogenicEtoposideI-kappa B KinaseI-kappa B ProteinsMAP Kinase Kinase KinasesMitogen-Activated Protein Kinase Kinase Kinase 11PARP1 protein, humanParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerases

Identifiers

PMID19782705
PMCPMC2788010
OpenAlexW2110135268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.